Israel:
Episode 20: Asaf Shiloni Of Kadimastem (Podcast)
03 November 2022
JMB Davis Ben-David
To print this article, all you need is to be registered or login on Mondaq.com.
Asaf Shiloni, a veteran biotech founder and manager is the CEO
of Kadimastem a clinical stage biotech company, that is creating
cell therapy that enables the production of off-the-shelf
cell-based products for the treatment of unmet medical needs such
as ALS and a cure for Diabetes.
Avraham sat down with Asaf in the offices of Kadimastem to
discuss how Kadimastem is creating and testing their innovative
therapies, why Israeli startups are so successful, the role of
patents in Kadimastem's business, tips for startup founders and
much more.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from Israel
GCC New Patent Amendments Effective January 01, 2023
Audiri Vox
The Gulf Cooperation Council (GCC) Patent Office has resumed handling of patent applications, examinations and annuities on behalf of the Kingdom of Bahrain and the State of Kuwait from January 01, 2023.
Dubai Customs Recycles 22,436 Counterfeit Items For 24 Brands
United Trademark & Patent Services
The Intellectual Property Department of Dubai Customs recycled 22,436 counterfeit items from 24 international brands. Counterfeit items included phones, watches, batteries, shoes, bags, accessories and cosmetics.